Old Web
English
Sign In
Acemap
>
authorDetail
>
B. San José-Ruiz Jimenez
B. San José-Ruiz Jimenez
Abiraterone acetate
Urology
Medicine
Prostate cancer
Prednisone
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Switching from prednisone to dexamethasone in metastatic castration resistant prostate cancer treated with abiraterone acetate in a multicenter study
2020
I. Rivero-Belenchón
C. Muñoz Calahorro
I. Osman-García
P. Beardo Villar
C.B. Congregado Ruiz
B. San José-Ruiz Jimenez
J. Campé Bartolo
R. Llarena Ibarguren
J. Extramina Cameno
R.A. Medina López
Show All
Source
Cite
Save
Citations (1)
Switch from prednisone to dexamethasone in patients with metastatic castration resistant prostate cancer (mCRPC) treated with abiraterone acetate (AA) in a multicenter study
2019
European Urology Supplements
I. Rivero-Belenchón
C. Muñoz Calahorro
I. Osman-García
P. Beardo Villar
C.B. Congregado Ruiz
B. San José-Ruiz Jimenez
J. Campé Bortolo
R. Llarena Ibarguren
J. Extramiana Cameno
R.A. Medina López
J.P. Pedraza-Sanchez
Show All
Source
Cite
Save
Citations (0)
Efficacy and safety of abiraterone acetate and enzalutamide treatment in a real-world setting in elderly chemotherapy-naive patients (≥ 75 years old)
2017
European Urology Supplements
B.T. Antón-Eguía
I. Osmán-García
P. Beardo Villar
B. San José-Ruiz Jimenez
C.B. Congregado-Ruiz
J. Campá-Bortolo
R. Llarena Ibarguren
J. Extramiana-Carmeno
R.A. Medina-López
Show All
Source
Cite
Save
Citations (0)
1